Crossmark

Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders

Crossref DOI link: https://doi.org/10.1007/s13311-015-0397-z

Published Print: 2016-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Valera, Elvira

Spencer, Brian

Masliah, Eliezer
Funding

Funding for this research was provided by:

National Institutes of Health (AG18440)

National Institutes of Health (AG022074)

National Institutes of Health (NS044233)
License Information

Text and Data Mining valid from 2016-01-01

Text and Data Mining valid from 2016-01-01

Version of Record valid from 2023-08-16
More Information

This article is maintained by: Elsevier

Article Title: Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-015-0397-z

Content Type: article

Copyright: Copyright © 2016 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.